EUVIMEDSkopri EUVIMED
Crossref

Transcatheter Aortic Valve Implantation in the Presence of Aortic Coarctation: Current Evidence and Practical Approaches

Vilhelmas Bajoras, Artiomas Širvys, Gintarė Petraitytė, Ričardas Kundelis, Liudas Usoris, Giedrius Davidavičius, Sigitas Čėsna

Catheterization and Cardiovascular Interventions · 2026-11-16

DOI: 10.1002/ccd.70982 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, published online on 2026-11-16. Written by Vilhelmas Bajoras and 6 co-authors. 35 references.

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Transcatheter aortic valve implantation (TAVI) has become an established treatment for severe aortic stenosis across a wide spectrum of surgical risk. As TAVI is increasingly used in younger patients and in those with congenital valve disease, the coexistence of aortic stenosis and untreated coarctation of the aorta (CoA) is being encountered more frequently. However, evidence guiding the procedural strategy in this complex anatomical setting remains limited.

Aims

To systematically review the published literature on TAVI in adult patients with untreated or residual coarctation of the aorta, focusing on patient characteristics, procedural strategies, vascular access selection, management of coexisting CoA, and clinical outcomes.

Methods

A systematic literature search was performed in PubMed, Wiley Online Library, ScienceDirect, and the Cochrane Library to identify published reports describing TAVI in adult patients with angiographically confirmed native or residual severe CoA. Case reports and case series published between January 2013 and September 2025 were included. Studies involving repaired CoA without restenosis or surgical aortic valve replacement were excluded. Clinical characteristics, access routes, procedural strategies, and outcomes were analyzed.

Results

Nine patients from published reports met the inclusion criteria. Hemodynamically significant CoA was present in five patients (55.6%). Bicuspid aortic valve anatomy was reported in six cases. Transcatheter access routes included transcarotid (44.4%), transfemoral (33.3%), transsubclavian (11.1%), and transaxillary (11.1%) approaches. A staged strategy with initial CoA stenting followed by TAVI was performed in two patients (22.2%), whereas seven patients (77.8%) underwent single‐procedure management, including concomitant treatment of both lesions in two cases. Procedural success was achieved in all cases, although technical challenges related to valve delivery and stent expansion were occasionally encountered.

Conclusions

TAVI in patients with untreated or residual CoA is feasible and can be performed with high procedural success when individualized strategies are applied. Access selection and the timing of CoA intervention should be guided by anatomical characteristics and hemodynamic severity. Given the limited evidence base, careful preprocedural planning and a multidisciplinary approach are essential to optimize outcomes in this complex patient population.

Cite

APA

Bajoras, V., Širvys, A., Petraitytė, G., Kundelis, R., Usoris, L., Davidavičius, G., & Čėsna, S. (2026). Transcatheter Aortic Valve Implantation in the Presence of Aortic Coarctation: Current Evidence and Practical Approaches. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70982

Vancouver

Bajoras V, Širvys A, Petraitytė G, Kundelis R, Usoris L, Davidavičius G, et al. Transcatheter Aortic Valve Implantation in the Presence of Aortic Coarctation: Current Evidence and Practical Approaches. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70982

BibTeX
@article{Bajoras2026,
  author = {Bajoras, Vilhelmas and Širvys, Artiomas and Petraitytė, Gintarė and Kundelis, Ričardas and Usoris, Liudas and Davidavičius, Giedrius and Čėsna, Sigitas},
  title = {Transcatheter Aortic Valve Implantation in the Presence of Aortic Coarctation: Current Evidence and Practical Approaches},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70982}
}
Start for free →